Amy Kelledes

Amy Kelledes possesses extensive experience in regulatory operations, currently serving as Senior Director at CRISPR Therapeutics since January 2019, where responsibilities include heading the Regulatory Operations department. Previously, Amy held various roles in regulatory operations at EMD Serono, Inc., and Boehringer Ingelheim, progressing from Associate Director to Specialist III across a span of over 13 years. Early career experience includes positions at Pfizer, focusing on regulatory CMC and analytical research. Amy holds a Bachelor’s Degree in Biology from Adrian College and a Certificate in Advanced Regulatory Affairs from San Diego State University.